|
Market Closed -
Nasdaq
23:00:00 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 5.930 USD | -2.15% |
|
-1.50% | -44.53% |
| 08-27 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-14 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 297M 256M 240M 219M 412M 28.36B 414M 2.84B 1.11B 14.32B 1.11B 1.09B 47.48B | P/E 2026 * |
-10.6x | P/E 2027 * | -13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 297M 256M 240M 219M 412M 28.36B 414M 2.84B 1.11B 14.32B 1.11B 1.09B 47.48B | EV / Sales 2026 * |
20x | EV / Sales 2027 * | 15x |
| Free-Float |
67.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : CapsoVision, Inc.
| 1 day | -2.15% | ||
| 1 week | -1.50% | ||
| Current month | -9.88% | ||
| 1 month | -10.56% | ||
| 3 months | -12.54% | ||
| 6 months | +8.01% | ||
| Current year | -44.53% |
| 1 week | 5.75 |  | 6.28 |
| 1 month | 5.75 | | 7.33 |
| Current year | 4.5 | | 11.37 |
| 1 year | 3.43 | | 15.37 |
| 3 years | 3.43 | | 15.37 |
| 5 years | 3.43 | | 15.37 |
| 10 years | 3.43 | | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 01/11/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 01/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 01/11/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 01/01/2025 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 01/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/17/26 A | Buy | Director | 61,068 | 0.1225% | ||
| 7/8/26 A | Buy | Director | 81,300 | 0.1631% | ||
| 7/1/26 A | Free | Director | 1,710 | 0.0034% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.15% | -1.50% | +58.13% | - | 297M | |
| +0.27% | -0.42% | -25.56% | -2.35% | 12.82B | |
| -3.83% | -6.27% | +9.74% | +5.11% | 4.41B | |
| -0.20% | -5.65% | -40.90% | -57.66% | 1.23B | |
| +1.00% | -0.63% | -37.51% | -41.90% | 1.16B | |
| +0.08% | -0.89% | +20.20% | +79.34% | 1.11B | |
| -1.14% | -1.20% | -37.11% | - | 1.05B | |
| -2.47% | +8.21% | - | - | 1.04B | |
| +0.95% | -3.68% | +28.58% | +115.33% | 536M | |
| +2.21% | -4.88% | -65.51% | +301.00% | 245M | |
| Average | -0.53% | +0.16% | -9.99% | +56.98% | 2.39B | |
| Weighted average by Cap. | -0.66% | +0.01% | -16.56% | +4.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 12.82M 12.02M 10.97M 20.66M 1.42B 20.73M 143M 55.62M 718M 55.84M 54.62M 2.38B | 19.82M 17.08M 16.02M 14.62M 27.54M 1.89B 27.63M 190M 74.13M 956M 74.42M 72.8M 3.17B |
| Net income | -27.56M -23.74M -22.26M -20.32M -38.28M -2.63B -38.41M -264M -103M -1.33B -103M -101M -4.41B | -22.1M -19.04M -17.86M -16.3M -30.71M -2.11B -30.8M -212M -82.65M -1.07B -82.97M -81.17M -3.54B |
| Net Debt | - | - |
Employees
99
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | $5.930 | -2.15% | 83,049 |
| 27/08/26 | $6.060 | +4.12% | 75,140 |
| 26/08/26 | $5.820 | -0.51% | 50,448 |
| 25/08/26 | $5.850 | +0.34% | 74,517 |
| 24/08/26 | $5.830 | -3.16% | 77,082 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.930USD
Average target price
9.500USD
Spread / Average Target
+60.20%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions
